As more corporations celebrate LGBTQ people each June, pride and profit are mixed — and so are the consequences
In their petition seeking review in the Oregon case, the bakery’s lawyers said hearing their appeal would allow the justices to answer the question left open last year. “It squarely presents the constitutional questions that the court did not answer in Masterpiece Cakeshop,” they wrote.
In the present report, the Independent Expert consequently focuses on the role of data in the creation of a state of heightened awareness of the scourge of violence and discrimination based on sexual orientation and gender identity; the risks associated with data collection, use and storage; and key human rights safeguards in that regard.
Victoria’s Secret is facing backlash for tweeting in support of the LGBTQ community for Pride Month
Over the course of June, you're likely to see a wide variety of brands and products getting a rainbow makeover just in time for Pride Month.
It's Pride month, and with 2019 the 50th anniversary of the Stonewall Riots, more companies than ever are looking to celebrate the LGBT community with capsule collections that embrace love, equality and diversity.
It's June, which means that Pride Month 2019 has officially arrived bringing a dazzling array of new rainbow themed merchandise to a retailer near you.
The number of products getting the rainbow treatment seems to grow, but it's a quite nice thing to be conflicted about
From M&S’s LGBT sandwich to Kendall Jenner stopping a riot with a Pepsi can, corporate business is adept at adopting our concerns. But is it all a cynical marketing ploy?
The global treaty seeks to determine the extent to which employers should protect LGBT+ workers and other vulnerable groups
This report, the ninth edition of the biennial OECD overview of social indicators, addresses the growing demand for quantitative evidence on social well-being and its trends.
The chief executive of Gilead Sciences, the nation’s leading manufacturer of HIV drugs, defended the high cost of a key drug that prevents the lethal infection, telling a House committee Thursday that its hefty profits pay for continued research.